Placental Lactogen Bovine

Placental Lactogen Bovine Recombinant

Recombinant Bovine Placental Lactogen is a single polypeptide chain with a molecular weight of 23 kDa. It consists of 199 amino acids and an additional alanine residue at the N-terminus. The purification process of this recombinant protein involves proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT29101
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized powder.

Placental Lactogen Caprine

Placental Lactogen Caprine Recombinant

Recombinant Caprine Placental Lactogen is a single polypeptide chain consisting of 199 amino acids, with an additional alanine residue at the N-terminus, resulting in a molecular weight of 23 kDa. The purification process of this recombinant protein involves proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT29213
Source
Escherichia Coli.
Appearance
White, lyophilized (freeze-dried) powder, sterile-filtered.

Placental Lactogen Human

Placental Lactogen Human Recombinant

Recombinant Human Placental Lactogen is a single polypeptide chain consisting of 199 amino acids, with an additional alanine residue at the N-terminus. Its molecular weight is approximately 22.4 kDa.
The purification process of Recombinant Placental Lactogen involves proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT29256
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized powder.

Placental Lactogen Ovine

Placental Lactogen Ovine Recombinant

Recombinant Ovine Placental Lactogen is a single-chain polypeptide composed of 199 amino acids, with an additional alanine residue at the N-terminus, resulting in a molecular weight of 23 kDa. The purification of Recombinant Placental Lactogen is achieved through proprietary chromatographic methods.
Shipped with Ice Packs
Cat. No.
BT29314
Source
Escherichia Coli.
Appearance
White, sterile-filtered lyophilized powder.

Placental Lactogen Sf9, Human

Placental Lactogen Human Recombinant, Sf9

Produced in Sf9 Baculovirus cells, Human Placental Lactogen is a single, glycosylated polypeptide chain comprising 197 amino acids (27-217 aa). With a molecular mass of 23.1kDa, it features a 6 amino acid His tag at the C-terminus and undergoes purification using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT29384
Source

Sf9, Baculovirus cells.

Appearance
A sterile, colorless solution.
Definition and Classification

Placental lactogen (PL), also known as chorionic somatomammotropin (CS), is a polypeptide hormone produced by the placenta during pregnancy. It belongs to the somatotropin family, which includes growth hormone (GH) and prolactin (PRL) . Human placental lactogen (hPL) is the specific form found in humans .

Biological Properties

Key Biological Properties: hPL shares significant homology with human growth hormone (hGH) and human prolactin (hPRL) . It is a protein hormone with a molecular mass of approximately 22,125 Da, consisting of a single chain of 191 amino acids linked by two disulfide bonds .

Expression Patterns: hPL is synthesized and secreted by the syncytiotrophoblast cells of the placenta . Its levels increase progressively throughout pregnancy, peaking near term .

Tissue Distribution: hPL is primarily found in the placenta and maternal serum during pregnancy .

Biological Functions

Primary Biological Functions: hPL plays a crucial role in regulating maternal metabolism to ensure an adequate supply of nutrients to the fetus . It promotes lipolysis, leading to increased free fatty acids for maternal energy use, while sparing glucose for fetal use . hPL also stimulates mammary gland development in preparation for lactation .

Role in Immune Responses and Pathogen Recognition: While hPL’s primary functions are metabolic and lactogenic, it may also have immunomodulatory effects, although this area requires further research .

Modes of Action

Mechanisms with Other Molecules and Cells: hPL interacts with prolactin receptors and, to a lesser extent, growth hormone receptors . It mimics the actions of prolactin in various tissues, including the mammary glands .

Binding Partners and Downstream Signaling Cascades: hPL binds to prolactin receptors with high affinity, activating downstream signaling pathways that promote mammary gland development and metabolic adaptations .

Regulatory Mechanisms

Regulatory Mechanisms: The expression of hPL is tightly regulated at both the transcriptional and post-transcriptional levels . Transcriptional regulation involves various nuclear hormone receptors and cytokines that activate the hPL promoter . Post-translational modifications, such as glycosylation, may also play a role in hPL’s stability and activity .

Applications

Biomedical Research: hPL is used as a marker for placental function and fetal well-being in pregnancy . It is also studied for its role in metabolic adaptations during pregnancy and its potential implications in gestational diabetes .

Diagnostic Tools: Measurement of hPL levels in maternal serum can help assess placental function and detect potential complications such as placental insufficiency .

Therapeutic Strategies: While not directly used as a therapeutic agent, understanding hPL’s role in pregnancy can inform strategies to manage gestational diabetes and other metabolic disorders .

Role in the Life Cycle

Role Throughout the Life Cycle: hPL is exclusively produced during pregnancy, with its levels rising in correlation with fetal and placental growth . It plays a vital role in fetal development by ensuring an adequate nutrient supply and preparing the maternal body for lactation . After childbirth, hPL levels rapidly decline .

© Copyright 2024 Thebiotek. All Rights Reserved.